Prognotic Role of CMR in Takotsubo Syndrome
Launched by UNIVERSITY OF CAGLIARI · Feb 21, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving how we assess and predict outcomes for patients with Takotsubo syndrome, a condition that affects the heart and can mimic a heart attack. The researchers aim to create a new scoring system that combines information from heart imaging tests to better understand the risks for patients. They will also look at how well these imaging results can predict what happens to patients during their hospital stay and in the long term. Additionally, they will compare this new scoring system with existing methods and explore how machine learning, a type of computer technology, can enhance predictions.
To participate in this study, you need to be an adult over 18 years old with a confirmed diagnosis of Takotsubo syndrome. You will need to have certain heart imaging tests done, including echocardiograms and cardiovascular magnetic resonance imaging. If you qualify, you can expect to provide some health information and undergo these tests. This research is important as it may lead to better ways to identify patients at risk and improve care for those experiencing this syndrome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Takotsubo syndrome diagnosis (according to Position Statement of the European Society of Cardiology Heart Failure Association)
- • Adult patients ( \> 18y old)
- • Availability at baseline of clinical variables, standard transthoracic echocardiography, and cardiovascular magnetic resonance acquisition
- Exclusion Criteria:
- • \<18 y old
- • Lack of transthoracic echocardiography and cardiovascular magnetic resonance examinations
- • Preexisting cardiomyopathies
- • Previous myocardial infarction
- • Suspected or known prior irreversible myocardial damage
- • Valvular heart disease
About University Of Cagliari
The University of Cagliari is a prominent academic institution located in Sardinia, Italy, renowned for its commitment to advancing medical research and education. With a strong emphasis on innovative clinical trials, the university leverages its interdisciplinary expertise and state-of-the-art facilities to drive advancements in healthcare. The institution collaborates with a network of researchers, clinicians, and industry partners to facilitate cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Through its rigorous scientific approach and dedication to ethical research practices, the University of Cagliari plays a pivotal role in contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cagliari, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported